Lapatinib Unknown Status Phase 2 Trials for Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00759642Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy